Significance of PRDM1β expression as a prognostic marker in diffuse large B-cell lymphomas Letter uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Lymphoma, B-Cell
  • Lymphoma, Large B-Cell, Diffuse
  • Repressor Proteins
  • Transcription Factors

publication date

  • February 15, 2008

Research

keywords

  • Letter

Identity

Digital Object Identifier (DOI)

  • 10.1182/blood-2007-09-111385

PubMed ID

  • 18263789

Additional Document Info

start page

  • 2488

end page

  • 9; author reply 2489-90

volume

  • 111

number

  • 4